A detailed history of Wellington Management Group LLP transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Wellington Management Group LLP holds 5,747,270 shares of IMCR stock, worth $195 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
5,747,270
Holding current value
$195 Million
% of portfolio
0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$60.14 - $75.36 $346 Million - $433 Million
5,747,270 New
5,747,270 $374 Million
Q4 2023

Feb 12, 2024

BUY
$42.85 - $69.5 $185 Million - $300 Million
4,312,611 New
4,312,611 $295 Million
Q3 2023

Nov 14, 2023

BUY
$49.5 - $66.6 $10.8 Million - $14.5 Million
217,920 Added 5.9%
3,913,410 $203 Million
Q2 2023

Aug 14, 2023

BUY
$48.54 - $61.64 $15.5 Million - $19.7 Million
320,181 Added 9.49%
3,695,490 $222 Million
Q1 2023

May 12, 2023

BUY
$46.12 - $65.71 $56.4 Million - $80.3 Million
1,222,343 Added 56.77%
3,375,309 $167 Million
Q4 2022

Feb 13, 2023

BUY
$45.51 - $65.08 $67.3 Million - $96.2 Million
1,478,233 Added 219.08%
2,152,966 $123 Million
Q3 2022

Nov 14, 2022

SELL
$37.34 - $57.44 $22.1 Million - $34 Million
-591,179 Reduced 46.7%
674,733 $31.7 Million
Q2 2022

Aug 15, 2022

SELL
$25.46 - $37.72 $1.95 Million - $2.88 Million
-76,447 Reduced 5.69%
1,265,912 $47.2 Million
Q1 2022

May 16, 2022

SELL
$18.94 - $34.29 $1.36 Million - $2.46 Million
-71,791 Reduced 5.08%
1,342,359 $40.1 Million
Q4 2021

Feb 11, 2022

BUY
$27.58 - $40.0 $9.99 Million - $14.5 Million
362,075 Added 34.42%
1,414,150 $48.4 Million
Q3 2021

Nov 15, 2021

BUY
$27.98 - $40.0 $21.3 Million - $30.4 Million
760,563 Added 260.9%
1,052,075 $39 Million
Q2 2021

Aug 16, 2021

BUY
$32.22 - $41.5 $1.42 Million - $1.83 Million
44,154 Added 17.85%
291,512 $11.4 Million
Q1 2021

May 17, 2021

BUY
$36.3 - $56.34 $8.98 Million - $13.9 Million
247,358 New
247,358 $10.5 Million

Others Institutions Holding IMCR

About Immunocore Holdings plc


  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.49B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.